Acute renal failure probably induced by prulifloxacin in an elderly woman: A first case report

Clinical Drug Investigation

Volumn 26, Issue 1, 2006, Pages 49-53

  Gallelli, L ^a   Gallelli, A ^a   Vero, G ^a   Roccia, F ^a   Pelaia, G ^a   De Sarro, G ^a   Maselli, R ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CEFTRIAXONE; FUROSEMIDE; GLYCERYL TRINITRATE; POTASSIUM; PRULIFLOXACIN; SULTAMICILLIN;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BRONCHITIS; CASE REPORT; COUGHING; DISEASE EXACERBATION; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LABORATORY TEST; NAUSEA; OLIGURIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCORING SYSTEM; VOMITING;

ACUTE KIDNEY INJURY; AGED; ANTI-BACTERIAL AGENTS; DIOXOLANES; FEMALE; FLUOROQUINOLONES; HUMANS; KIDNEY FAILURE, ACUTE; PIPERAZINES; QUINOLONES;

EID: 30744437424     PISSN: 11732563     EISSN: 11732563     Source Type: Journal    
DOI: 10.2165/00044011-200626010-00007     Document Type: Article

References (27)

1. Ozaki M, Matsuda M, Tomii Y, et al. In vivo evaluation of NM441, a new thiazeto-quinoline derivative. Antimicrob Agents Chemother 1991; 35: 2496-9
2. Grassi C, Salvatori E, Rosignoli MT, et al. Randomized, doubleblind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis. Respiration 2002; 69: 217-22
3. Reato G, Cuffini AM, Tullio V, et al. Immunomodulating effect of antimicrobial agents on cytokine production by human polymorphonuclear neutrophils. Int J Antimicrob Agents 2004; 23: 150-4
4. Tullio V, Cuffini AM, Bonino A, et al. Influence of a new fluoroquinolone, AF3013 (the active metabolite of pruliflox-acin) on macrophage functions against Klebsiella pneumoniae: an in vitro comparison with pefloxacin. J Antimicrob Chemother 2000; 46: 241-7
5. Angelini ACRAF SpA. Investigator's brochure: Unidrox. prulifloxacin 600mg tablets. Rome: ACRAF SpA, 2004
6. Naranjo CA, Busto U, Sellers EM, et al. A method for estimat-ing the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45
7. Grossman RF. Guidelines for the treatment of acute exacerbation of chronic bronchitis. Chest 1997; 112: 310S-3S
8. Balter MS, La Forge J, Low DE, et al. Canadian guidelines for the management of acute exacerbations of chronic bronchitis: executive summary. Can Respir J 2003; 10: 248-58
9. Mandell LA, Bartlett JG, Dowell SF, et al. Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immuno-competent adults. Clin Infect Dis 2003; 37: 1405-33
10. Gallelli L, Del Negro S, Naty S, et al. Levofloxacin-induced taste perversion, blurred vision and dyspnoea in a young woman. Clin Drug Invest 2004; 24: 487-9
11. Kawaminami A, Tawaratani T, Ishibashi S, et al. Renal toxicity of prulifloxacin (NM441) in rats. J Toxicol Sci 1996; 21: 267-76
12. Singh AK, Ucci A, Madias NE. Predominant tubulointerstitial lupus nephritis. Am J Kidney Dis 1996; 27: 273-8
13. Townend BS, Sturm JW, Whyte S. Quinine associated blind-ness. Aust Fam Physician 2004; 33: 627-8
14. Reddy JC, Shuman MA, Aster RH. Quinine/quinidine-induced thrombocytopenia: a great imitator. Arch Intern Med. 2004; 164: 218-20
15. Pawar R, Jacobs GH, Smith MC. Quinine-associated acute interstitial nephritis. Am J Kidney Dis. 1994; 24: 211-4
16. Muller M, Strand S, Hug H, et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 1997; 99: 403
17. Faubion WA, Guicciardi ME, Miyoshi H, et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999; 103: 137-45
18. Zhang H, Cook J, Nickel J, et al. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis. Nat Biotechnol 2000; 18: 862-7
19. Zinszner H, Kuroda M, Wang XZ, et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 1998; 12: 982-95
20. Lorz C, Justo P, Sanz A, et al. Paracetamol-induced renal tubular injury: a role for ER stress. J Am Soc Nephrol 2004; 15: 380-9
21. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000; 11: 319-29
22. Silbiger SR, Neugarten J. The role of gender in the progression of renal disease. Adv Ren Replace Ther 2003; 10: 3-14
23. Kang DH, Yu ES, Yoon KI, et al. The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol 2004; 164: 679-88
24. Lipsky BA, Baker CA. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis 1999; 28: 352-64
25. Hootkins R, Fenves AZ, Stephens MK. Acute renal failure secondary to oral ciprofloxacin therapy: a presentation of three casesand a review of the literature. Clin Nephrol 1989; 32: 75-8
26. Allon M, Lopez EJ, Min KW. Acute renal failure due to ciprofloxacin. Arch Intern Med 1990; 150: 2187-9
27. Malhotra S, Karan RS, Pandhi P, et al. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77: 703-7